OpenBilldrug price receipt

NADAC week of 2026-10-14

RUFINAMIDE 200 MG TABLET

For 30 tablets

Pharmacies pay

$26.43 filed

30 × $0.881 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.

The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$35.39 estimated

$26.43 + $3.96 (15%) + $5.00 fee per fill = $35.39

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

RUFINAMIDE 200 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as rufinamide.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 6 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc., Camber Pharmaceuticals, Inc. and Micro Labs Limited.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under 6 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $26.43 for 30 tablets (30 × $0.881 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

What NADAC measures · Why 30 tablets · NADAC explanation codes

All 6 NDCs

Other strengths, forms and brands

5 other products in the NADAC file share the FDA nonproprietary name rufinamide with RUFINAMIDE 200 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
BANZEL 40 MG/ML SUSPENSION
brand · suspension		$3.64872 per ML filed
eff. 2026-09-23		We don’t know yet
BANZEL 200 MG TABLET
brand · tablet, film coated		$12.61034 per EA filed
eff. 2026-09-23		We don’t know yet
BANZEL 400 MG TABLET
brand · tablet, film coated		$25.18264 per EA filed
eff. 2026-09-23		We don’t know yet
RUFINAMIDE 40 MG/ML SUSPENSION
generic · suspension		$0.20341 per ML filed
eff. 2026-09-23		We don’t know yet
RUFINAMIDE 200 MG TABLET this page
generic · tablet, film coated / tablet		$0.881 per EA filed
eff. 2026-09-23		We don’t know yet
RUFINAMIDE 400 MG TABLET
generic · tablet, film coated / tablet		$1.39131 per EA filed
eff. 2026-09-23		We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

More